NCT06629493

Brief Summary

The main objective is to assess the feasibility and effectiveness of using activity trackers to increase physical activity and improve the emotional state of people receiving an in-patient treatment for alcohol use disorder

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 4, 2022

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

July 30, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 8, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 2, 2025

Completed
Last Updated

September 22, 2025

Status Verified

October 1, 2024

Enrollment Period

3.2 years

First QC Date

July 30, 2024

Last Update Submit

September 16, 2025

Conditions

Keywords

activity trackeralcohol use disorderphysical activitytreatmentmental health

Outcome Measures

Primary Outcomes (8)

  • Physical activity tracker adherence

    Days (percentage) in which activity tracker was used (day-time and night-time use)

    Treatment duration (4 weeks)

  • Physical activity tracker perceived utility

    Perceived utility with the physical activity tracker will be assessed using ad-hoc questions about the utility of the activity tracker to increase levels of physical activity, improve sleep quality, and reduce/abandon tobacco.

    End-of-treatment (4 weeks)

  • Physical activity levels

    Physical activity (PA) is operationalized as steps per day, plants climbed per day, distance covered per day (kilometers), light physical activity (minutes per day), moderate physical activity (minutes per week), vigorous physical activity (minutes per week), and sedentary time (hours per day). These outcomes will be measured using an adapted version of the International Physical Activity Questionnaire (IPAQ) and Fitbit Versa 3®.

    In-treatment (4 weeks), from enrollment to end-of treatment (4 weeks)

  • Depression symptoms

    Depression symptoms will be measured using the Patient Health Questionnaire-9 (PHQ-9). This questionnaire ranges from 0 to 14. A higher punctuation means higher depression symptom levels.

    From enrollment to the end-of-treatment (4 weeks)

  • Anxiety symptoms

    Anxiety symptoms will be measured using Generalized Anxiety Disorder-7 (GAD-7). This questionnaire ranges from 0 to 21. Higher punctuation means higher anxiety levels symptoms.

    From enrollment to the end-of-treatment (4 weeks)

  • Difficulties in emotion regulation

    Emotion dysregulation is measured using the Difficulties in Emotion Regulation Scale (DERS). Emotional dysregulation of negative emotions is measured with the Difficulties in Emotion Regulation Scale (DERS). This scale ranges from 28 to 140 points. A higher score means more difficulties in emotion regulation.

    From enrollment to the end-of-treatment (4 weeks)

  • Physical activity tracker acceptability

    Acceptability of the activity tracker is measured using the Participant Experience Questionnaire (PEQ). This scale ranges from 10 to 50 points. A higher score means higher acceptability.

    End-of-treatment (4 weeks)

  • Sleep quality

    Sleep quality will be measured using both the Pittsburg Sleep Quality Index (PSQI) and the Fitbit Versa 3. PSQI ranges from 0 to 21 points. A higher score means lower sleep quality. In addition, Fitbit Versa 3 provides a sleep quality punctuation ranging from 0 to 100. A higher punctuation means better sleep quality.

    In-treatment (4 weeks), from enrollment to the end-of-treatment (4 weeks)

Secondary Outcomes (2)

  • Tobacco use

    In treatment (4 weeks), from enrollment to the end-of-treatment (4 weeks)

  • Delay discounting (impulsive decision making)

    From enrollment to the end-of-treatment (4 weeks)

Study Arms (2)

Alcohol use disorder treatment plus Fitbit Versa 3

EXPERIMENTAL

Participants will receive in-patient treatment for alcohol use disorder plus an activity tracker

Behavioral: Fitbit Versa 3Behavioral: In-patient alcohol use disorder treatment

Alcohol use disorder treatment

ACTIVE COMPARATOR

Participants will receive in-patient treatment for alcohol use disorder

Behavioral: In-patient alcohol use disorder treatment

Interventions

Fitbit Versa 3BEHAVIORAL

Fitbit Versa 3 is a commercially available activity tracker

Alcohol use disorder treatment plus Fitbit Versa 3

In-patient alcohol use disorder treatment, including group therapy, counseling, and occupational activities

Alcohol use disorder treatmentAlcohol use disorder treatment plus Fitbit Versa 3

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being 18 years old or older.
  • Be undergoing inpatient treatment for alcohol use disorder.

You may not qualify if:

  • Finishing the treatment before 4 weeks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Therapeutical community "La Santina"

Gijón, Principality of Asturias, 33394, Spain

Location

Related Publications (4)

  • Scott CK, Dennis ML, Gustafson DH. Reprint of Using ecological momentary assessments to predict relapse after adult substance use treatment. Addict Behav. 2018 Aug;83:116-122. doi: 10.1016/j.addbeh.2018.04.003. Epub 2018 Apr 7.

    PMID: 29661655BACKGROUND
  • Purani H, Friedrichsen S, Allen AM. Sleep quality in cigarette smokers: Associations with smoking-related outcomes and exercise. Addict Behav. 2019 Mar;90:71-76. doi: 10.1016/j.addbeh.2018.10.023. Epub 2018 Oct 17.

    PMID: 30368021BACKGROUND
  • Brickwood KJ, Watson G, O'Brien J, Williams AD. Consumer-Based Wearable Activity Trackers Increase Physical Activity Participation: Systematic Review and Meta-Analysis. JMIR Mhealth Uhealth. 2019 Apr 12;7(4):e11819. doi: 10.2196/11819.

    PMID: 30977740BACKGROUND
  • Abrantes AM, Blevins CE, Battle CL, Read JP, Gordon AL, Stein MD. Developing a Fitbit-supported lifestyle physical activity intervention for depressed alcohol dependent women. J Subst Abuse Treat. 2017 Sep;80:88-97. doi: 10.1016/j.jsat.2017.07.006. Epub 2017 Jul 8.

    PMID: 28755778BACKGROUND

Related Links

MeSH Terms

Conditions

Substance-Related DisordersAlcohol-Related DisordersAlcoholismMotor ActivityPsychological Well-Being

Interventions

Ethanol

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental DisordersBehaviorPersonal Satisfaction

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, PhD

Study Record Dates

First Submitted

July 30, 2024

First Posted

October 8, 2024

Study Start

April 4, 2022

Primary Completion

July 1, 2025

Study Completion

July 2, 2025

Last Updated

September 22, 2025

Record last verified: 2024-10

Locations